Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DECITABINE vs DEFERASIROX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DECITABINE vs DEFERASIROX: Safety Overview

Metric DECITABINE DEFERASIROX
Total FAERS Reports 2,983 11,322
Deaths Reported 816 2,661
Death Rate 27.4% 23.5%
Hospitalizations 1,060 4,008
Average Patient Age 56.2 yrs 49.8 yrs
% Female Patients 43.2% 50.1%
FDA Approval Date Apr 12, 2021 Apr 11, 2025
Manufacturer Qilu Pharmaceutical Co., Ltd. AvKARE
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription